Why DuPont's Restructuring Will Likely Pay Off

Chemicals giant E.I. du Pont de Nemours & Company  (NYSE: DD  ) is embarking on a new age for itself, one that has involved an aggressive restructuring of its business over the past few years. First, DuPont acquired global enzyme and specialty food ingredient company Danisco for nearly $6 billion in 2011. The following year, DuPont sold off its Performance Coatings unit to The Carlyle Group (NASDAQ: CG  ) for $5 billion.

Unfortunately, these initiatives haven't provided the results management wanted so far. And yet, management is entirely confident in the company's future. DuPont's revenue growth is slowing, which has called its strategic shift into question. It seems as though the key consideration for investors going forward is whether you believe management's vision will ultimately pay off.

Do you buy DuPont's value proposition?
DuPont labels itself as a company optimally positioned for high growth and value, due to its new business structure which management believes is focused on the best opportunities. Unfortunately, progress has been slow to materialize. Consider that DuPont generated just 3% sales growth in 2013. Sluggish sales growth last year was due to poor performance in its Performance Chemicals and Electronics segments, which posted sales declines of 7% and 6%, respectively.

Going forward, DuPont is focusing on three key segments: Agriculture & Nutrition, Advancement Materials, and Industrial Biosciences. Collectively, DuPont management feels its business is best positioned to serve these markets. That's because these are where rising demand for better food and advanced fuels and materials create highly promising growth opportunities.

While results haven't shown up yet, there's reason to believe DuPont's strategy is the right one. The underlying economics of the agriculture industry are extremely favorable. That's because global populations continue to expand, and rapidly emerging economies have placed an enormous strain on food production. In addition, DuPont's existing Agriculture division was is best-performing business segment last year, since it produced 13% sales growth and is the company's largest operating unit.

Divestments across the industry
DuPont's strategy of aggressively selling off business divisions not deemed critical to future operations is emblematic of the entire chemicals industry. Chemicals companies across the board are tightening their belts and slimming down, preparing to do more with less. For example, Dow Chemical (NYSE: DOW  ) announced plans last year to sell off its chlorine segment, which was its oldest business. This move was part of a plan to divest various businesses that amounted to $5 billion in annual revenue. The goal here is to shore up its balance sheet and raise cash in a broader initiative called the "Efficiency for Growth" plan.

It's worth noting that shareholders are seeing immediate benefits from this strategy in the form of greater cash returns. Dow recently increased its dividend by 15% as well as expanded its share repurchase authorization to $4.5 billion, to be completed this year.

At the same time, caution is warranted because Dow's core underlying business is struggling. Its net sales grew by just a fraction of a percent last year. Profitability expanded significantly—adjusted earnings jumped 30% in 2013—but bottom-line growth was due largely to share buybacks and aggressive cost cuts. Long-term earnings growth is limited without sales growth cooperating.

Management ability is the true test
Chemicals companies are embarking on an 'out with the old, in with the new' mentality. They're disposing of older business segments that have suffered slowing growth in recent years. Going forward, the strategic shifts will pave the way for more profitable long-term futures from the higher-value opportunities DuPont and Dow are turning their efforts toward.

DuPont's focus on agriculture seems like a wise move. The favorable economics of the agriculture industry represent a strong tailwind. Plus, DuPont's agriculture business was its best-performing segment last year in terms of sales growth. As a result, the path for success is already there.

Still, shedding profitable, time-tested business segments is a risky move. In the end, whether these decisions prove to be profitable ones depends largely on management's ability to execute their plans.

Warren Buffett has publicly backed Dow, what else can we learn?

Warren Buffett has made billions through his investing and he wants you to be able to invest like him. Through the years, Buffett has offered up investing tips to shareholders of Berkshire Hathaway. Now you can tap into the best of Warren Buffett's wisdom in a new special report from The Motley Fool. Click here now for a free copy of this invaluable report.

Read/Post Comments (3) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On February 13, 2014, at 2:09 PM, funfundvierzig wrote:

    DuPont's restructuring is likely to pay off?

    We respectfully demur. DuPont Chieftess, Ellen J. Kullman, and her predecessor and mentor, former Chief, Chad O. Holliday, Jr., have been "restructuring", transforming, and dramatically shrinking the DuPont Company for 16 years since 1998! All the time, this duo promised high growth and value. It simply has not happened. Shares of DuPont are trading today for less than DD opened the new century @ 65 7/8 on Jan. 3, 2000.

    Nor is DuPont any longer a "giant". The much diminished DuPont, for example is a third the size of BASF by a number of financial metrics, and half the size of Dow Chemical.

    In our opinion, as long as basically, the same inbred and questionably competent Management remains entrenched in Delaware, DuPont will continue to go rigourously nowhere. This unwieldy conglomerate struggling with severe identity confusion lacks the intellectual capital to compete effectively with the reigning world leaders in agriculture and nutrition, Monsanto, Syngenta, Scotts MIRACLE-GRO, and Novozymes.

    Merely the perspective of one individual retail investor, long DOW, MON, SYT, and short DD...funfun..

  • Report this Comment On February 13, 2014, at 2:13 PM, funfundvierzig wrote:

    It is telling that only this week, Andrew Liveris, Dow Chemical Chief, has publicly and decisively rejected the simple-minded business model of DuPont, SHRINKAGE Equals GROWTH, and declared Dow will not be serially butchered into parts and sold or spun off. ...funfun..

  • Report this Comment On April 03, 2014, at 4:01 PM, mikewatson021 wrote:

    I think the company is going in the right direction organically and inorganically. Their sales have been increasing in all geographic locations with high growth. That would neutralize the foreign exchange risk and falling local prices.

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2837701, ~/Articles/ArticleHandler.aspx, 9/4/2015 2:57:43 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Bob Ciura

Bob Ciura, MBA, has written for The Motley Fool since 2012. I focus on energy, consumer goods, and technology. I look for growth at a reasonable price, with a particular fondness for market-beating dividend yields.

Today's Market

updated Moments ago Sponsored by:
DOW 16,044.35 -330.41 -2.02%
S&P 500 1,916.13 -35.00 -1.79%
NASD 4,663.06 -70.44 -1.49%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/4/2015 2:38 PM
CG $20.01 Down -0.55 -2.68%
Carlyle Group CAPS Rating: ***
DD $49.04 Down -1.52 -3.01%
E.I. du Pont de Ne… CAPS Rating: ****
DOW $41.94 Down -0.89 -2.08%
The Dow Chemical C… CAPS Rating: ****